Hemab Therapeutics Holdings
COAG
#4642
Rank
A$3.37 B
Marketcap
A$72.30
Share price
6.51%
Change (1 day)
N/A
Change (1 year)

Hemab Therapeutics Holdings (COAG) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : A$0.53 Billion

According to Hemab Therapeutics Holdings's latest financial reports the company's total liabilities are A$0.53 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Hemab Therapeutics Holdings - Total liabilities on balance sheet (from 2026 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31A$0.55 B63.04%
2024-12-31A$0.34 B